Skip to main content
NeuronFeed

Commure vs Kilow

Which Healthcare AI tool is better in 2026?

Commure

$860M

Kilow

$2.5M

Side-by-side

Verdict

Commure is the more established option (raised $860M); pricing is comparable on both sides.

Metric Commure Kilow
Taglinei
Foundedi 2024🏆
HQi Riyadh, Saudi Arabia
Employeesi 11-50 11-50
Neuron scorei 78🏆 60
Total fundingi $860M🏆 $2.5M
Latest roundi Growth · May 2026 Seed
Valuationi $7B🏆
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Free Free
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Commure and Kilow.

Capability Commure Kilow
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Commure

  • Has raised more capital ($860M vs $2.5M)
  • Higher Neuron score (78 vs 60)

🔵 Strengths of Kilow

  • Newer company (2024)

Which should you choose?

Choose Kilow if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Commure if you want the most established option — it has raised $860M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Commure vs Kilow — which is better?

It depends on your priority. Commure has raised more capital and is the more established option; Kilow has broader feature depth. See the side-by-side table above.

Is Commure cheaper than Kilow?

No — Kilow's cheapest paid plan is Free, while Commure's is Free.

Do Commure and Kilow offer free plans?

Commure: Yes, has a free plan. Kilow: Yes, has a free plan.

Contextual paths to related AI startups, deals and rankings.